Does WHO/ISUP grade 3–4 affect oncologic outcomes in pathologic T1 renal cell carcinoma after surgical treatment?
Canadian Journal of Urology · 2026 · 1-10
DOI: 10.32604/cju.2026.071548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Urology, 2026. Verfasst von Chinade Roper und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Background: Current NCCN guidelines recommend a more rigorous imaging schedule for patients whose surgical pathology for renal cell carcinoma (RCC) includes adverse pathological features such as higher grade (grade 3–4). How... | Find, read and cite all the research you need on Tech Science Press
Zitieren
APA
Roper, C., Yong, C., Slaven, J., Black, M., Zhang, W., Patrick, E., DeMichael, K., Wesson, T., O’Brien, S., Farrell, R., Belamkar, A., Boris, R., Bahler, C., & Sundaram, C. (2026). Does WHO/ISUP grade 3–4 affect oncologic outcomes in pathologic T1 renal cell carcinoma after surgical treatment?. Canadian Journal of Urology, 0(0), 1-10. https://doi.org/10.32604/cju.2026.071548
Vancouver
Roper C, Yong C, Slaven J, Black M, Zhang W, Patrick E, et al. Does WHO/ISUP grade 3–4 affect oncologic outcomes in pathologic T1 renal cell carcinoma after surgical treatment?. Canadian Journal of Urology. 2026;0(0):1-10. doi:10.32604/cju.2026.071548
BibTeX
@article{Roper2026,
author = {Roper, Chinade and Yong, Courtney and Slaven, James and Black, Morgan and Zhang, William and Patrick, Elise and DeMichael, Kelly and Wesson, Troy and O’Brien, Sean and Farrell, Rowan and Belamkar, Ameya and Boris, Ronald and Bahler, Clinton and Sundaram, Chandru},
title = {Does WHO/ISUP grade 3–4 affect oncologic outcomes in pathologic T1 renal cell carcinoma after surgical treatment?},
journal = {Canadian Journal of Urology},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/cju.2026.071548}
}
EUVIMED